Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide

被引：0
|
作者：
A A N Giagounidis
A Kulasekararaj
U Germing
R Radkowski
S Haase
P Petersen
G Göhring
G Büsche
C Aul
G J Mufti
U Platzbecker
机构：
[1] Katholisches Klinikum Duisburg,
[2] St Johannes Hospital,undefined
[3] King's College Hospital,undefined
[4] Heinrich-Heine-Universität,undefined
[5] Medizinische Hochschule Hannover,undefined
[6] Technische Universität Dresden,undefined
[7] Universitätsklinikum Carl Gustav Carus,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：855 / 858
页数：3
相关论文
共 50 条
  • [1] Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomide
    Giagounidis, A. A. N.
    Kulasekararaj, A.
    Germing, U.
    Radkowski, R.
    Haase, S.
    Petersen, P.
    Goehring, G.
    Buesche, G.
    Aul, C.
    Mufti, G. J.
    Platzbecker, U.
    LEUKEMIA, 2012, 26 (04) : 855 - 858
  • [2] Long-term transfusion independence in del(5q) patients despite discontinuation of lenalidomide
    Giagounidis, A.
    Gohring, G.
    Haase, S.
    Heinsch, M.
    Banisch, S.
    Aul, C.
    Schlegelberger, B.
    LEUKEMIA RESEARCH, 2009, 33 : S126 - S127
  • [3] Long-term transfusion independence in del(5q) MDS patients after short term therapy with lenalidomide: 2 new cases
    Himmelmann, Andreas
    Tchinda, Joelle
    LEUKEMIA RESEARCH, 2012, 36 (05) : 656 - 657
  • [4] MODELLING THE LONG-TERM SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS) DEL (5Q) TREATED WITH LENALIDOMIDE
    Benettaib, B.
    Lee, D.
    Dhanasiri, S.
    Brereton, N.
    HAEMATOLOGICA, 2013, 98 : 310 - 310
  • [5] Long-term outcome of MDS with del 5q before the lenalidomide era. The GFM experience
    Kelaidi, C.
    Park, S.
    Tamburini, J.
    Sapena, R.
    Raffoux, E.
    Beyne-Rauzy, O.
    Coiteux, V.
    Aljassem, L.
    Prebet, T.
    Legros, L.
    Stamatoullas, A.
    Sanhes, L.
    Delarue, R.
    Dreyfus, F.
    Fenaux, P.
    LEUKEMIA RESEARCH, 2009, 33 : S124 - S124
  • [6] Cytopenias correlate with response to lenalidomide in del 5q MDS patients
    Sekeres, M. A.
    Maciejewski, J. P.
    Giagounidis, A.
    Wride, K.
    Knight, R.
    List, A.
    LEUKEMIA RESEARCH, 2007, 31 : S37 - S38
  • [7] Lenalidomide reexposure After Short Interruption In Del(5q) MDS Patients at Relapse of Transfusion Dependence
    Radkowski, Robert Marek
    Haase, Sabine
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Banisch, Stefanie
    Heinsch, Michael
    Aul, Carlo
    Giagounidis, Aristoteles
    BLOOD, 2010, 116 (21) : 1204 - 1204
  • [8] Disease progression in del(5q) MDS patients treated with lenalidomide: analysis of risk factors and long-term outcome in 44 patients
    Giagounidis, A. A. N.
    Haase, S.
    Lohrbacher, V.
    Heinsch, M.
    Schuran, B.
    Aul, C.
    LEUKEMIA RESEARCH, 2007, 31 : S120 - S121
  • [9] Lenalidomide in AML: Del(5q) or who?
    Steensma, David P.
    Stone, Richard M.
    BLOOD, 2011, 118 (03) : 481 - 482
  • [10] Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study
    Crisa, Elena
    Mora, Elvira
    Germing, Ulrich
    Bally, Cecile
    Campelo, Maria Diez
    Myllymaki, Mikko
    Jadersten, Martin
    Komrokji, Rami
    Platzbecker, Uwe
    Haase, Detlef
    Hofmann, Wolf-Karsten
    Al Ali, Najla H.
    Barraco, Daniela
    Bargay, Juan Jose
    Bernal, Teresa
    Cadenas, Felix Lopez
    Calvisi, Anna
    Capodanno, Isabella
    Cerrano, Marco
    Ciancia, Rosanna
    Crugnola, Monica
    Kundgen, Andrea
    Finelli, Carlo
    Fozza, Claudio
    Frairia, Chiara
    Freja, Ebeling
    Ganster, Christina
    Kubasch, Anne Sophie
    Jimenez, Maria Jose
    Latagliata, Roberto
    Mohedo, Francisca Hernandez
    Molero, Antonieta
    Pampliega, Miriam Vara
    Perez, Clara Aparicio
    Pietrantuono, Giuseppe
    Poloni, Antonella
    Pomares, Helena
    Recasens, Valle
    Rufer, Axel
    Signori, Alessio
    Hellstrom-Lindberg, Eva
    Fenaux, Pierre
    Sanz, Guillermo
    Santini, Valeria
    LEUKEMIA, 2024, 38 (10) : 2259 - 2265
12345